Sells umbilical-cord stem-cell products to regenerative healthcare facilities and provides stem-cell treatments to patients through its clinics.
10-K for FY2025, filed Mar 31, 2026The Company’s medical and supplement divisions aim to boost health and vitality through innovation and expansion. Adia Med leads with a…View ↗
Partnerships with top medical entities help expand access to regenerative medicine. Full clinics with apheresis machines will also offer…View ↗
Our Adia Med operation administers our biologic products using trained medical professionals to treat conditions or ailments whose negative…View ↗
ADIA earns revenue chiefly from biologic product sales to regenerative healthcare facilities and medical procedures for patients. It also earns revenue from supplement sales, ancillary products, shipping and delivery, and other services.
10-K for FY2025, filed Mar 31, 2026
10-K for FY2025, filed Mar 31, 2026
FY2025 revenue by product or service ↗$700.5K
10-K for FY2025, filed Mar 31, 2026
$700.5K ↗| Segment | Share | Revenue |
|---|---|---|
|
Sales Of Supplements
|
0.5% |
Sales Of Supplements, FY2025
$3.4K Sources
|
|
Medical Procedures
|
35% |
Medical Procedures, FY2025
$245.6K Sources
|
|
Sales Of Biologics
|
63% |
Sales Of Biologics, FY2025
$443.8K Sources
|
|
Sales Of Ancillary Products
|
0.1% |
Sales Of Ancillary Products, FY2025
$360 Sources
|
|
Shipping And Delivery
|
0.7% |
Shipping And Delivery, FY2025
$5.1K Sources
|
|
Services
|
0.3% |
Services, FY2025
$2.3K Sources
|
Regenerative healthcare facilities buy biologic products directly from Adia Labs; Adia Med administers biologic treatments to patients. Consumers buy supplements through the company’s website and other direct-to-consumer channels.
10-K for FY2025, filed Mar 31, 2026
No. It lost $395.5K in FY2025.
10-K for FY2025, filed Mar 31, 2026
−$366.5KView ↗
10-K for FY2025, filed Mar 31, 2026
−$395.5KView ↗
10-K for FY2025, filed Mar 31, 2026
−$192.4KView ↗
10-Q for Q2 FY2026, filed Aug 13, 2026
Open tableView ↗
Growing.
Revenue grew 109.8x in 1 year, from $6.4K in FY2024 to $700.5K in FY2025, about 10880% a year.
10-K for FY2025, filed Mar 31, 2026
Loading...